Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Transposon Mutagenesis in Mycobacterium avium Subspecies Paratuberculosis.

Bannantine JP, Zinniel DK, Barletta RG.

Methods Mol Biol. 2019;2016:117-125. doi: 10.1007/978-1-4939-9570-7_11.

PMID:
31197714
2.

Novel Amphiphilic Cyclobutene and Cyclobutane cis-C18 Fatty Acid Derivatives Inhibit Mycobacterium avium subsp. paratuberculosis Growth.

Zinniel DK, Sittiwong W, Marshall DD, Rathnaiah G, Sakallioglu IT, Powers R, Dussault PH, Barletta RG.

Vet Sci. 2019 May 24;6(2). pii: E46. doi: 10.3390/vetsci6020046.

3.

The pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery.

Szalewski DA, Hinrichs VS, Zinniel DK, Barletta RG.

Can J Microbiol. 2018 Jul;64(7):439-453. doi: 10.1139/cjm-2017-0749. Epub 2018 Mar 27. Review.

4.

Pathogenesis, Molecular Genetics, and Genomics of Mycobacterium avium subsp. paratuberculosis, the Etiologic Agent of Johne's Disease.

Rathnaiah G, Zinniel DK, Bannantine JP, Stabel JR, Gröhn YT, Collins MT, Barletta RG.

Front Vet Sci. 2017 Nov 6;4:187. doi: 10.3389/fvets.2017.00187. eCollection 2017. Review.

5.

Assessment of Metabolic Changes in Mycobacterium smegmatis Wild-Type and alr Mutant Strains: Evidence of a New Pathway of d-Alanine Biosynthesis.

Marshall DD, Halouska S, Zinniel DK, Fenton RJ, Kenealy K, Chahal HK, Rathnaiah G, Barletta RG, Powers R.

J Proteome Res. 2017 Mar 3;16(3):1270-1279. doi: 10.1021/acs.jproteome.6b00871. Epub 2017 Feb 14.

PMID:
28121156
6.

Whole genomic sequence analysis of Bacillus infantis: defining the genetic blueprint of strain NRRL B-14911, an emerging cardiopathogenic microbe.

Massilamany C, Mohammed A, Loy JD, Purvis T, Krishnan B, Basavalingappa RH, Kelley CM, Guda C, Barletta RG, Moriyama EN, Smith TP, Reddy J.

BMC Genomics. 2016 Aug 22;17 Suppl 7:511. doi: 10.1186/s12864-016-2900-2.

7.

Analysis of Mycobacterium avium subsp. paratuberculosis Mutant Libraries Reveals Loci-dependent Transposition Biases and Strategies to Novel Mutant Discovery.

Rathnaiah G, Bannantine JP, Bayles DO, Zinniel DK, Stabel JR, Gröhn YT, Barletta RG.

Microbiology. 2016 Feb 16. doi: 10.1099/mic.0.000258. [Epub ahead of print]

PMID:
26888023
8.

Generation and screening of a comprehensive Mycobacterium avium subsp. paratuberculosis transposon mutant bank.

Rathnaiah G, Lamont EA, Harris NB, Fenton RJ, Zinniel DK, Liu X, Sotos J, Feng Z, Livneh-Kol A, Shpigel NY, Czuprynski CJ, Sreevatsan S, Barletta RG.

Front Cell Infect Microbiol. 2014 Oct 15;4:144. doi: 10.3389/fcimb.2014.00144. eCollection 2014.

9.

A rational framework for evaluating the next generation of vaccines against Mycobacterium avium subspecies paratuberculosis.

Bannantine JP, Hines ME 2nd, Bermudez LE, Talaat AM, Sreevatsan S, Stabel JR, Chang YF, Coussens PM, Barletta RG, Davis WC, Collins DM, Gröhn YT, Kapur V.

Front Cell Infect Microbiol. 2014 Sep 9;4:126. doi: 10.3389/fcimb.2014.00126. eCollection 2014. Review.

10.

Evaluation of eight live attenuated vaccine candidates for protection against challenge with virulent Mycobacterium avium subspecies paratuberculosis in mice.

Bannantine JP, Everman JL, Rose SJ, Babrak L, Katani R, Barletta RG, Talaat AM, Gröhn YT, Chang YF, Kapur V, Bermudez LE.

Front Cell Infect Microbiol. 2014 Jul 1;4:88. doi: 10.3389/fcimb.2014.00088. eCollection 2014.

11.

Development of cyclobutene- and cyclobutane-functionalized fatty acids with inhibitory activity against Mycobacterium tuberculosis.

Sittiwong W, Zinniel DK, Fenton RJ, Marshall DD, Story CB, Kim B, Lee JY, Powers R, Barletta RG, Dussault PH.

ChemMedChem. 2014 Aug;9(8):1838-49. doi: 10.1002/cmdc.201402067. Epub 2014 Jun 5.

12.

Evaluation of novel oral vaccine candidates and validation of a caprine model of Johne's disease.

Hines ME 2nd, Turnquist SE, Ilha MR, Rajeev S, Jones AL, Whittington L, Bannantine JP, Barletta RG, Gröhn YT, Katani R, Talaat AM, Li L, Kapur V.

Front Cell Infect Microbiol. 2014 Mar 4;4:26. doi: 10.3389/fcimb.2014.00026. eCollection 2014.

13.

Molecular analysis of the Mycobacterium tuberculosis lux-like mel2 operon.

Janagama HK, Tounkang S, Cirillo SL, Zinniel DK, Barletta RG, Cirillo JD.

Tuberculosis (Edinb). 2013 Dec;93 Suppl:S83-7. doi: 10.1016/S1472-9792(13)70016-7.

PMID:
24388655
14.

Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria.

Halouska S, Fenton RJ, Zinniel DK, Marshall DD, Barletta RG, Powers R.

J Proteome Res. 2014 Feb 7;13(2):1065-76. doi: 10.1021/pr4010579. Epub 2013 Dec 13.

15.

Revisiting Protocols for the NMR Analysis of Bacterial Metabolomes.

Halouska S, Zhang B, Gaupp R, Lei S, Snell E, Fenton RJ, Barletta RG, Somerville GA, Powers R.

J Integr OMICS. 2013 Dec;3(2):120-137.

16.

Sample preparation of Mycobacterium tuberculosis extracts for nuclear magnetic resonance metabolomic studies.

Zinniel DK, Fenton RJ, Halouska S, Powers R, Barletta RG.

J Vis Exp. 2012 Sep 3;(67):e3673. doi: 10.3791/3673.

17.

Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

Halouska S, Fenton RJ, Barletta RG, Powers R.

ACS Chem Biol. 2012 Jan 20;7(1):166-71. doi: 10.1021/cb200348m. Epub 2011 Dec 1.

18.

Characterization of the Mycobacterium avium subsp. paratuberculosis laminin-binding/histone-like protein (Lbp/Hlp) which reacts with sera from patients with Crohn's disease.

Lefrançois LH, Pujol C, Bodier CC, Teixeira-Gomez AP, Drobecq H, Rosso ML, Raze D, Dias AA, Hugot JP, Chacon O, Barletta RG, Locht C, Vidal Pessolani MC, Biet F.

Microbes Infect. 2011 Jun;13(6):585-94. doi: 10.1016/j.micinf.2011.02.002. Epub 2011 Feb 18.

PMID:
21334452
19.

Immunogenicity and reactivity of novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and conserved MAP1156 proteins with sera from experimentally and naturally infected animals.

Bannantine JP, Paulson AL, Chacon O, Fenton RJ, Zinniel DK, McVey DS, Smith DR, Czuprynski CJ, Barletta RG.

Clin Vaccine Immunol. 2011 Jan;18(1):105-12. doi: 10.1128/CVI.00297-10. Epub 2010 Nov 17.

20.

Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.

Bruning JB, Murillo AC, Chacon O, Barletta RG, Sacchettini JC.

Antimicrob Agents Chemother. 2011 Jan;55(1):291-301. doi: 10.1128/AAC.00558-10. Epub 2010 Oct 18.

21.
22.

A Kinetic Study of In Vitro Lysis of Mycobacterium smegmatis.

Valente W, Pienaar E, Fast A, Fluitt A, Whitney S, Fenton R, Barletta R, Chacon O, Viljoen H.

Chem Eng Sci. 2009 May 1;64(9):1944-1952.

23.

Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages.

Chacon O, Bermudez LE, Zinniel DK, Chahal HK, Fenton RJ, Feng Z, Hanford K, Adams LG, Barletta RG.

Microbiology. 2009 May;155(Pt 5):1440-50. doi: 10.1099/mic.0.024901-0. Epub 2009 Apr 21.

PMID:
19383714
24.

Plasmid transformation and expression of the firefly luciferase in Microbacterium testaceum type and endophytic colonizing field strains.

Zinniel DK, Feng Z, Blum PH, Barletta RG, Vidaver AK.

Can J Microbiol. 2008 Nov;54(11):964-70. doi: 10.1139/w08-086.

PMID:
18997853
25.

Genetic resistance of mice to Mycobacterium paratuberculosis is influenced by Slc11a1 at the early but not at the late stage of infection.

Roupie V, Rosseels V, Piersoel V, Zinniel DK, Barletta RG, Huygen K.

Infect Immun. 2008 May;76(5):2099-105. doi: 10.1128/IAI.01137-07. Epub 2008 Feb 19.

26.

ATP release by infected bovine monocytes increases the intracellular survival of Mycobacterium avium subsp. paratuberculosis.

Woo SR, Barletta RG, Czuprynski CJ.

Comp Immunol Microbiol Infect Dis. 2009 Sep;32(5):365-77. doi: 10.1016/j.cimid.2007.11.003. Epub 2008 Feb 19.

PMID:
18243311
27.

Demonstration of allelic exchange in the slow-growing bacterium Mycobacterium avium subsp. paratuberculosis, and generation of mutants with deletions at the pknG, relA, and lsr2 loci.

Park KT, Dahl JL, Bannantine JP, Barletta RG, Ahn J, Allen AJ, Hamilton MJ, Davis WC.

Appl Environ Microbiol. 2008 Mar;74(6):1687-95. doi: 10.1128/AEM.01208-07. Epub 2008 Jan 11.

28.

Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase.

Halouska S, Chacon O, Fenton RJ, Zinniel DK, Barletta RG, Powers R.

J Proteome Res. 2007 Dec;6(12):4608-14. Epub 2007 Nov 3.

29.
30.

Life and death in bovine monocytes: the fate of Mycobacterium avium subsp. paratuberculosis.

Woo SR, Heintz JA, Albrecht R, Barletta RG, Czuprynski CJ.

Microb Pathog. 2007 Aug-Sep;43(2-3):106-13. Epub 2007 May 10.

PMID:
17548182
31.

Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice.

Rosseels V, Roupie V, Zinniel D, Barletta RG, Huygen K.

Infect Immun. 2006 Jun;74(6):3684-6.

32.

Bovine monocytes and a macrophage cell line differ in their ability to phagocytose and support the intracellular survival of Mycobacterium avium subsp. paratuberculosis.

Woo SR, Sotos J, Hart AP, Barletta RG, Czuprynski CJ.

Vet Immunol Immunopathol. 2006 Mar 15;110(1-2):109-20. Epub 2005 Oct 26.

PMID:
16256206
33.

Application of the genome sequence to address concerns that Mycobacterium avium subspecies paratuberculosis might be a foodborne pathogen.

Bannantine JP, Barletta RG, Stabel JR, Paustian ML, Kapur V.

Foodborne Pathog Dis. 2004 Spring;1(1):3-15. Review.

PMID:
15992257
34.

[Gene inactivation in Mycobacterium tuberculosis and its use in tuberculosis control and prevention].

Chacón O, Realpe T, Barletta RG, Robledo J.

Biomedica. 2004 Jun;24 Supp 1:165-87. Review. Spanish.

PMID:
15495585
35.

Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis.

Chacon O, Bermudez LE, Barletta RG.

Annu Rev Microbiol. 2004;58:329-63. Review.

PMID:
15487941
36.

Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus.

Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E, Zuckermann F, Osorio FA.

Vaccine. 2004 Jan 2;22(3-4):467-74.

PMID:
14670329
37.
39.

Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus.

Bastos RG, Dellagostin OA, Barletta RG, Doster AR, Nelson E, Osorio FA.

Vaccine. 2002 Nov 22;21(1-2):21-9.

PMID:
12443659
40.

Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens.

Broxmeyer L, Sosnowska D, Miltner E, Chacón O, Wagner D, McGarvey J, Barletta RG, Bermudez LE.

J Infect Dis. 2002 Oct 15;186(8):1155-60. Epub 2002 Sep 30.

PMID:
12355367
41.

Antigenicity of Mycobacterium paratuberculosis superoxide dismutase in mice.

Mullerad J, Hovav AH, Fishman Y, Barletta RG, Bercovier H.

FEMS Immunol Med Microbiol. 2002 Sep 6;34(1):81-8.

43.

The immunogenicity of Mycobacterium paratuberculosis 85B antigen.

Mullerad J, Michal I, Fishman Y, Hovav AH, Barletta RG, Bercovier H.

Med Microbiol Immunol. 2002 Mar;190(4):179-87.

PMID:
12005331
44.

Molecular cloning, sequencing, and characterization of bovine transporter associated with antigen processing 2 ( BoTAP2).

Ambagala AP, Feng Z, Barletta RG, Srikumaran S.

Immunogenetics. 2002 Apr;54(1):30-8. Epub 2002 Mar 2.

PMID:
11976789
45.

Isolation and characterization of endophytic colonizing bacteria from agronomic crops and prairie plants.

Zinniel DK, Lambrecht P, Harris NB, Feng Z, Kuczmarski D, Higley P, Ishimaru CA, Arunakumari A, Barletta RG, Vidaver AK.

Appl Environ Microbiol. 2002 May;68(5):2198-208.

46.

Cell sorting of formalin-treated pathogenic Mycobacterium paratuberculosis expressing GFP.

Harris NB, Zinniel DK, Hsieh MK, Cirillo JD, Barletta RG.

Biotechniques. 2002 Mar;32(3):522-4, 526-7.

47.

Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth.

Chacon O, Feng Z, Harris NB, Cáceres NE, Adams LG, Barletta RG.

Antimicrob Agents Chemother. 2002 Jan;46(1):47-54.

48.

Identification of a secreted superoxide dismutase in Mycobacterium avium ssp. paratuberculosis.

Liu X, Feng Z, Harris NB, Cirillo JD, Bercovier H, Barletta RG.

FEMS Microbiol Lett. 2001 Aug 21;202(2):233-8.

49.

Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Harris NB, Barletta RG.

Clin Microbiol Rev. 2001 Jul;14(3):489-512. Review.

50.

Vaccines against intracellular pathogens.

Barletta RG, Donis RO, Chacón O, Shams H, Cirillo JD.

Subcell Biochem. 2000;33:559-99. Review. No abstract available.

PMID:
10804870

Supplemental Content

Loading ...
Support Center